News

PharmiWeb.com
pharmiweb.com > press-release > 2026-03-12 > carna-health-marks-world-kidney-day-with-scaling-of-ckd-screening-program-to-four-continents

Carna Health Marks World Kidney Day with Scaling of CKD Screening Program to Four Continents

1+ hour, 41+ min ago  (144+ words) AI-driven screening programs aim to detect chronic kidney disease earlier, prevent progression, and reach millions worldwide Caribbean: Bermuda Leads the Way Following this pilot, Bermuda's Ministry of Health established a CKD Integrated Care Pathway in 2023, institutionalizing structured screening and care…...

PharmiWeb.com
pharmiweb.com > press-release > 2026-03-11 > c2n-diagnostics-enters-south-korean-market-through-partnership-with-beaubrain-healthcare-to-offer-pr

C2N Diagnostics Enters South Korean Market Through Partnership with BeauBrain Healthcare to Offer Pr

1+ day, 2+ hour ago  (306+ words) ST. LOUIS--(BUSINESS WIRE)--#Alzheimers--C2N Diagnostics, LLC (C2N), a specialty diagnostics company with a vision to bring Clarity Through Innovation, has reached an agreement with BeauBrain Healthcare that brings its breakthrough diagnostic testing for Alzheimer's disease to South Korea. Notably, 72% of…...

PharmiWeb.com
pharmiweb.com > press-release > 2026-03-10 > innoviva-specialty-therapeutics-earns-strong-performance-rating-in-access-to-medicine-foundation-s-2

Innoviva Specialty Therapeutics Earns Strong Performance Rating in Access to Medicine Foundation’s 2

2+ day, 6+ hour ago  (1022+ words) Report Highlights the Company's Collaboration with GARDP to Develop NUZOLVENCE" (zoliflodacin) for Oral Suspension for the Treatment of Uncomplicated Urogenital Gonorrhea in Adults and Pediatric PatientsWALTHAM, Mass.--(BUSINESS WIRE)--Innoviva Specialty Therapeutics, a subsidiary of Innoviva Inc., today announced that…...

PharmiWeb.com
pharmiweb.com > press-release > 2026-03-10 > immutep-partners-with-flex-databases-to-digitize-clinical-trial-documentation

Immutep Partners with Flex Databases to Digitize Clinical Trial Documentation

2+ day, 3+ hour ago  (268+ words) Prague, Czech Republic " Flex Databases is pleased to announce that Immutep GmbH has implemented Flex Databases eTMF to enhance the management of its Trial Master File (TMF) documentation across ongoing clinical studies. This move underscores Immutep's commitment to improving efficiency,…...

PharmiWeb.com
pharmiweb.com > press-release > 2026-03-10 > c-further-unveils-first-therapeutic-programmes-dedicated-to-paediatric-oncology

C-Further Unveils First Therapeutic Programmes Dedicated to Paediatric Oncology

2+ day, 7+ hour ago  (333+ words) C-Further to advance its first two bespoke paediatric cancer therapeutics in collaboration with leading global academic and industry investigators Additional C-Further programmes to be announced in 2026 The selected research partners represent top academic and industry investigators from across the globe,…...

PharmiWeb.com
pharmiweb.com > press-release > 2026-03-11-1 > qiagen-receives-us-clearance-for-gastrointestinal-panels-on-fully-automated-qiastat-dx-rise-syndro

QIAGEN Receives U.S. Clearance for Gastrointestinal Panels on Fully Automated QIAstat-Dx Rise Syndro

1+ day, 19+ hour ago  (321+ words) GERMANTOWN, Md. & VENLO, Netherlands--(BUSINESS WIRE)--$QGEN #QIAGEN--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that the U.S. Food and Drug Administration (FDA) has cleared the use of all QIAstat-Dx" Gastrointestinal (GI) Panels on the QIAstat-Dx Rise automated syndromic testing…...

PharmiWeb.com
pharmiweb.com > press-release > 2026-03-10 > tiximed-announces-promising-preclinical-data-oral-tix100-prevents-weight-regain-after-glp-1-cessati

TIXiMED Announces Promising Preclinical Data: Oral TIX100 Prevents Weight Regain After GLP-1 Cessati

1+ day, 22+ hour ago  (723+ words) TIX100 prevented weight regain in mice after semaglutide discontinuationSupports potential role as oral weight maintenance therapy following GLP-1 Receptor Agonist (GLP-1) treatment, addressing a major challenge in long-term obesity managementBIRMINGHAM, Ala.--(BUSINESS WIRE)--#GLP1--TIXiMED, Inc., a clinical-stage pharmaceutical company developing a…...

PharmiWeb.com
pharmiweb.com > press-release > 2026-03-10 > connectiverx-advances-clinically-integrated-provider-engagement-network

ConnectiveRx Advances Clinically Integrated Provider Engagement Network

1+ day, 19+ hour ago  (499+ words) Industry's largest provider network activates 1.2 million HCPs, supported by physician-level data and reportingWHIPPANY, N.J.--(BUSINESS WIRE)--ConnectiveRx, a leading provider of technology-enabled patient support and access solutions for specialty and branded medications, today highlighted the scale and precision of its clinically…...

PharmiWeb.com
pharmiweb.com > press-release > 2026-03-10 > niagen-bioscience-launches-niagen-skincare-innovation-lab-and-debuts-dermatologist-tested-niagen-na

Niagen Bioscience Launches Niagen® Skincare Innovation Lab and Debuts Dermatologist-Tested Niagen Na

2+ day, 4+ hour ago  (284+ words) Launch expands Niagen" into the growing skincare category through a limited-release model designed to generate consumer insights and inform future innovation Rob Fried, Chief Executive Officer of Niagen Bioscience, commented, "Niagen Skincare Innovation Lab is a strategic step into exploring…...

PharmiWeb.com
pharmiweb.com > press-release > 2026-03-10 > bioaffinity-technologies-announces-initiation-of-large-scale-longitudinal-clinical-study-for-its-non

bioAffinity Technologies Announces Initiation of Large-Scale Longitudinal Clinical Study for Its Non

1+ day, 22+ hour ago  (166+ words) Study to evaluate clinical performance of CyPath" Lung for the early detection of lung cancer in high-risk patients Murtha Cancer Center Research Program at Uniformed Services University of the Health Sciences provides support for longitudinal study Physicians currently order CyPath…...